Literature DB >> 15615645

Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death.

Stuart C Feinstein1, Leslie Wilson.   

Abstract

Interest in the microtubule-associated protein tau stems from its critical roles in neural development and maintenance, as well as its role in Alzheimer's, FTDP-17 and related neurodegenerative diseases. Under normal circumstances, tau performs its functions by binding to microtubules and powerfully regulating their stability and growing and shortening dynamics. On the other hand, genetic analyses have established a clear cause-and-effect relationship between tau dysfunction/mis-regulation and neuronal cell death and dementia in FTDP-17, but the molecular basis of tau's destructive action(s) remains poorly understood. One attractive model suggests that the intracellular accumulation of abnormal tau aggregates causes cell death, i.e., a gain-of-toxic function model. Here, we describe the evidence and arguments for an alternative loss-of-function model in which tau-mediated neuronal cell death is caused by the inability of affected cells to properly regulate their microtubule dynamic due to mis-regulation by tau. In support of this model, our recent data demonstrate that missense FTDP-17 mutations that alter amino acid residues near tau's microtubule binding region strikingly modify the ability of tau to modulate microtubule dynamics. Additional recent data from our labs support the notion that the same dysfunction occurs in the FTDP-17 regulatory mutations that alter tau RNA splicing patterns. Our model posits that the dynamics of microtubules in neuronal cells must be tightly regulated to enable them to carry out their diverse functions, and that microtubules that are either over-stabilized or under-stabilized, that is, outside an acceptable window of dynamic activity, lead to neurodegeneration. An especially attractive aspect of this model is that it readily accommodates both the structural and regulatory classes of FTDP-17 mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15615645     DOI: 10.1016/j.bbadis.2004.07.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  66 in total

1.  Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

Authors:  Donna M Barten; Patrizia Fanara; Cathy Andorfer; Nina Hoque; P Y Anne Wong; Kristofor H Husted; Gregory W Cadelina; Lynn B Decarr; Ling Yang; Victoria Liu; Chancy Fessler; Joan Protassio; Timothy Riff; Holly Turner; Christopher G Janus; Sethu Sankaranarayanan; Craig Polson; Jere E Meredith; Gemma Gray; Amanda Hanna; Richard E Olson; Soong-Hoon Kim; Gregory D Vite; Francis Y Lee; Charles F Albright
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 2.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

3.  Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain.

Authors:  Robert A Whittington; László Virág; Maud Gratuze; Hilana Lewkowitz-Shpuntoff; Mehdi Cheheltanan; Franck Petry; Isabelle Poitras; Françoise Morin; Emmanuel Planel
Journal:  Neurobiol Aging       Date:  2018-11-08       Impact factor: 4.673

4.  Taxol and tau overexpression induced calpain-dependent degradation of the microtubule-destabilizing protein SCG10.

Authors:  Irving E Vega; Tadanori Hamano; Josh A Propost; Gabriele Grenningloh; Shu-Hui Yen
Journal:  Exp Neurol       Date:  2006-07-05       Impact factor: 5.330

5.  Ethanol enhances tau accumulation in neuroblastoma cells that inducibly express tau.

Authors:  Tania F Gendron; Sharon McCartney; Ena Causevic; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2008-07-24       Impact factor: 3.046

6.  Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation.

Authors:  Jack Reifert; DeeAnn Hartung-Cranston; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2011-04-11       Impact factor: 5.157

7.  Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts.

Authors:  Erkan Kiris; Donovan Ventimiglia; Mehmet E Sargin; Michelle R Gaylord; Alphan Altinok; Kenneth Rose; B S Manjunath; Mary Ann Jordan; Leslie Wilson; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

8.  Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.

Authors:  K I Seyb; E R Schuman; J Ni; M M Huang; M L Michaelis; M A Glicksman
Journal:  J Biomol Screen       Date:  2008-09-23

9.  Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action.

Authors:  H Eric Feinstein; Sarah J Benbow; Nichole E LaPointe; Nirav Patel; Srinivasan Ramachandran; Thanh D Do; Michelle R Gaylord; Noelle E Huskey; Nicolette Dressler; Megan Korff; Brady Quon; Kristi Lazar Cantrell; Michael T Bowers; Ratnesh Lal; Stuart C Feinstein
Journal:  J Neurochem       Date:  2016-04-20       Impact factor: 5.372

Review 10.  Anesthesia and tau pathology.

Authors:  Robert A Whittington; Alexis Bretteville; Maya F Dickler; Emmanuel Planel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-25       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.